Latest Edition Highlights (Issue 39)

Featured articles from our most recent publication

DETECTION OF EPSTEIN-BARR VIRUS (EBV) IN WOMEN WITH BREAST CANCER IN IRAQ USING IN-SITU HYBRIDIZATION AND IMMUNOHISTOCHEMICAL TECHNIQUES

Background: The Epstein-Barr virus (EBV) has recently been identified in human breast cancer globally, potentially contributing to the initiation and progression of this malignancy, as well as gastric cancer, nasopharyngeal carcinoma, and bladder cancer. It has been newly associated with breast cancer. Globally, breast cancer affects more women than any other type of cancer. In Iraq, the prevalence of breast cancer is comparable. Aims: The study examined Iraqi women diagnosed with invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) to detect Epstein-Barr Virus Nuclear Antigen-1 (EBNA-1) and encoded RNA (EBER). Methods: A total of 50 formalin-fixed paraffin-embedded tissues from invasive ductal carcinoma (IDC) (92%) and invasive lobular carcinoma (ILC) (8%) biopsy samples constituted the case group, while 30 formalin-fixed paraffin-embedded tissues from non-cancerous breast tissue served as the control group. The presence of Epstein-Barr virus protein (EBER) in breast tissue was assessed using immunohistochemistry (IHC) and chromogenic in situ hybridization (CISH) methods. Results: EBER RNA signals were found in 31 (62%). EBER RNA signals were seen in 3 (10%) control group participants. Significant differences (P<0.04) were seen in EBV EBER RNA positive signals among study groups. Immunohistochemistry showed nuclear brown staining in 34 (68%) breast cancer patients. Control group: 3 (10%). Discussion: The research identified a statistically significant correlation between EBV positivity and breast cancer among Iraqi women, especially concerning invasive ductal carcinoma. The results corroborate previous reports of elevated EBV levels in malignant breast tissues relative to controls. Although detection approaches such as CISH and IHC provide complementary insights, additional studies are needed. Conclusions: The study concludes that EBNA-1 and EBV EBER RNA were overexpressed in our population group.
Read Article

RESEARCH LANDSCAPE OF REPURPOSED MEDICATIONS IN CANCER TREATMENT: A MULTI-DATABASE BIBLIOMETRIC ANALYSIS OF ELEVEN OFF-PATENT THERAPEUTICS

Background: Drug repurposing offers potential advantages for cancer therapy development, particularly when utilizing medications with established safety profiles and expired patents. While individual repurposed medications have been investigated for oncological applications, comprehensive comparative analyses of research distribution patterns across multiple therapeutic candidates appear limited in the literature. Understanding these patterns may provide insights into research priorities and potential knowledge gaps. Aim: This exploratory study was designed to quantify and compare the volume of scientific literature examining the anticancer potential of eleven selected off-patent medications across different pharmacological classes. Methods: Bibliometric searches were conducted across five databases (Google Scholar, BVS, PubMed, NIH, and Science.gov) using standardized search terms combining each medication name with "cancer" and "cancer treatment." The selected medications included ivermectin, fenbendazole, mebendazole, albendazole, metformin, propranolol, disulfiram, valproic acid, thalidomide, dexamethasone, and hydroxychloroquine. Basic statistical analyses were performed to examine the distribution patterns and correlations within the database. Results: The search yielded 3,226,066 total publications with considerable variation in distribution patterns. Dexamethasone accounted for the largest proportion (1,538,058 publications, 47.68%), followed by metformin (697,172 publications, 21.61%). Some medications with smaller overall publication volumes demonstrated higher proportions of treatment-specific research, such as fenbendazole (87.82%), disulfiram with copper (86.54%), and hydroxychloroquine with zinc (75.21%). The Herfindahl Index indicated a high concentration of research attention (0.2870). Discussion: The findings suggest substantial variation in research attention across the selected medications. While some medications dominate the literature, others with focused treatment-specific research may warrant further investigation. The inverse relationship observed between total publication volume and treatment specificity suggests that research patterns in this field may be more complex than absolute publication counts indicate. Conclusions: This preliminary bibliometric assessment reveals an uneven distribution of research attention among repurposed medications being investigated for cancer applications. These patterns may inform future research prioritization, though further qualitative analysis would be valuable to assess the clinical significance of these quantitative observations.
Read Article

TREATMENTS FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A COMPARISON BETWEEN TISAGENLECLEUCEL AND CLOFARABINE

Background: Acute lymphoblastic leukemia (ALL) is a heterogeneous hematological malignancy predominantly affecting individuals under 20 years of age. Traditional chemotherapy, such as clofarabine, has shown efficacy; however, novel immunotherapeutic strategies like tisagenlecleucel (Kymriah®) have significantly altered the treatment paradigm. Aim: This study aimed to perform a comparative analysis of tisagenlecleucel, a CAR-T cell therapy, and clofarabine, a second-generation purine nucleoside analog, evaluating their mechanisms of action, therapeutic benefits, limitations, and clinical applicability across diverse patient populations. Methods: A systematic comparative evaluation was conducted, encompassing pharmacological characteristics, mechanisms of action, treatment protocols, efficacy, safety profiles, and clinical indications of both agents. The analysis considered pharmacokinetic and pharmacodynamic data and included patient demographic variables. Results: Tisagenlecleucel demonstrated high efficacy in refractory B-cell ALL, with durable responses and a blood half-life of 128 days, but with notable immune-related adverse effects such as cytokine release syndrome. Clofarabine, effective across a broader patient population, acts via multiple antitumor mechanisms but carries significant toxicity risks, including infection and sepsis. Discussion: The therapies present distinct clinical profiles: tisagenlecleucel offers targeted immunotherapy with high specificity but requires specialized infrastructure and management of immune toxicities. Clofarabine is more widely accessible and applicable, but is associated with conventional chemotherapy-related side effects. Treatment accessibility and cost differ markedly between the two. Conclusions: Therapy selection should be personalized based on patient-specific factors and institutional resources. Tisagenlecleucel is ideal for pediatric and young adult patients with relapsed/refractory B-cell ALL in CAR-T-capable centers, while clofarabine remains a viable option for broader ALL populations, particularly when genetic therapies are not feasible. Further research is needed to optimize therapeutic strategies and improve access to advanced treatments.
Read Article

General information

SOUTHERN JOURNAL OF SCIENCES

    General information about this journal
  • Title: SOUTHERN JOURNAL OF SCIENCES
  • Short Title: South. J. Sci.
  • ISSN: 2764-5959 (Online); ISSN: 2764-5967 (Print)
  • Universal Decimal Classification (UDC): 001
  • Review Process: Double-Blind Peer-Review
  • Accessibility: Platinum Open Access, NO-APCs.
  • Digital preservation: Portico
  • Frequency of Publication: biannual [2 issues per year]. Journal publication schedule
  • DOI: 10.48141/2764-5959
  • Website: https://www.sjofsciences.com/
  • Country: BRAZIL
  • Publisher: Araucária - Scientific Association.
  • Language of Publication: ENGLISH / PORTUGUESE*
  • *Year that the Journal started accepting manuscripts in Portuguese: 2020
  • First issue year: 1993
  • Free full text: Yes
  • Indexed in: Index Copernicus; Latindex, and I2OR.
  • Formerly known as the Southern Brazilian Journal of Chemistry (1993 to 2021).
  • Former ISSN: 2674-6891 (Online); Former ISSN: 0104-5431 (Print).
  • Website last update: 06/07/2025.

Journal last cover


Last Cover

DOWNLOAD

Selected Articles for Additional Reading (2018 - Present)

Discover more great content from our archive

(Cu0.4Al0.3)TaSe2: PREPARATION AND CRYSTAL STRUCTURE ANALYSIS FROM X-RAY POWDER DIFFRACTION

A new phase of the (CuAlSe2)1-x(TaSe)x alloy system was synthesized by the melt and annealingtechnique and studied by SEM, DTA, and XRPD techniques. Its structure has been refined by the Rietveld methodusing X-ray powder diffraction data. The new alloy corresponds with the stoichiometry Cu0.4Al0.3TaSe2. Thiscompound crystallizes in the hexagonal space group 𝑃6ത𝑚2 (Nº 187) with a MoS2-type structure, and unit cellparameters a = 3.455(2) Å, c = 13.423(4) Å, V = 138.7(1) Å3, Z =2. The crystal structure is based on the MoS2-type of stacking of TaSe2 layers with a partial ordering of Cu and Al cations over the tetrahedral sites. The powderpattern was composed of 63.1% of the principal phase Cu0.4Al0.3TaSe2 and 29.9% of CuAlSe2, 7.0% of TaSe3, asthe secondary phases. 
Read Article

USING SYNTHESISED ORGANIC COMPOUNDS AS ENVIRONMENTALLY FRIENDLY RETARDANTS FOR ORNAMENTAL PLANTS

The pre-sowing treatment of scarlet sage (Salvia splendens Ker Gawl.) seeds with 4-methyl-2-piperidin1-yl-pyrimidine-5-carboxylic acid at concentrations of 0.01, 0.05, and 0.1% proved to have an obvious inhibiting effect. Prior to sowing, the seeds of Salvia splendens were soaked in a water suspension of 4-methyl-2-piperidin-1-yl-pyrimidine-5-carboxylic acid and 4-methyl-2-morpholin-4-pyrimidine-5-carboxylic acid with concentrations of 0.01%, 0.05%, and 0.1% for 18 hours. On the 42nd day of the experiment, the seedlings, having been preliminarily hardened for 12 days, were removed from the greenhouse and planted on the field. The pre-sowing treatment of Salvia splendens seeds with 4-methyl-2-morpholin-4-pyrimidine-5-carboxylic acid proved to have the inhibiting effect at concentrations of 0.01 and 0.05%. The height of the seedlings decreased by 13.3-43.7%. It was revealed that 4-methyl-2-piperidin-1-yl-pyrimidine-5-carboxylic acid at concentrations of 0.01, 0.05, and 0.1% decreased the growth of the seedlings by 30.4-43.7%, and 4-methyl-2-morpholin-4-pyrimidine-5-carboxylic acid at concentrations of 0.01 and 0.05% decreased the growth of the seedlings by13.3-22.2%. By contrast, the effect of pyrimidinecarboxylic acids on seed germination and plant height of another annual flower – spreading marigold (Tagetes patula L.) was stimulating. It was investigated some different concentrations from 0.01 to 0.05 %. The same concentrations of identical compounds were tested, but effects from them were opposite for Tagetes patula, and Salvia splendens seedlings. Сonsequently, the species-specific effect of pyrimidinecarboxylic acids on seed germination and plant height for ornamental grasses takes place. Therefore,4-methyl-2-piperidin-1-yl-pyrimidine-5-carboxylic acid and 4-methyl-2-morpholin4-pyrimidine-5-carboxylic acid are recommended as growth retardants for Salvia splendens. 
Read Article

GRAPHICAL METHOD FOR DETERMINATION OF MQ-SERIES GAS SENSOR CIRCUIT PARAMETERS FOR A STAND-ALONE GAS ALARM SYSTEM

Background: MQ-series gas sensors belong to the metal oxide semiconductor (MOS) family of sensors that can sense the presence of many gases. These sensors find their application in gas alarm systems as key components. While necessary sensor circuit output voltage value for alarm point in a stand-alone gas alarm system is desirable, but what exact combination of the sensor circuit parameters is required? Hitherto, the determination of these circuit parameters has not been given much attention in the research community. Aim: the purpose of this work is to explore a structured graphical approach of determination of MQ series gas sensor circuit parameters for a stand-alone gas alarm system that yields desired sensor circuit output voltage value for the alarm point; the main objective of the study was to develop mathematical model equations that relate the: (i) sensor resistance (RS) with the gas concentration (x) and the sensor resistance at standard calibration concentration of the sensor base gas in the clean air (Ro) and (ii) sensor circuit output voltage (VRL), load resistance (RL) and sensor resistance (RS). It is expected from the model equations developed that graphical correlations of the sensor circuits parameters will be generated. Using these graphs for a particular case of an MQ-4 gas sensor under the influence of LPG, the parameters that yield desired sensor circuit output voltage of 2V for 1000 ppm of LPG alarm point will be determined. Methods: Model equations were developed for the sensor dynamics, and based on these model equations, graphs for the determination of required sensor parameters were plotted for a case of MQ-4 gas sensor response to LPG. Results and Discussion: The results yielded optimal values for R_O,R_S and R_L of 20 kΩ, 30 kΩ and 20 kΩ respectively, for alarm settings of 1000 ppm and a desired sensor circuit output voltage of 2 V. Based on determined parameters, the calibration equation for determination of best concentration value for a given value of emulated LPG concentration was developed. Using the method proposed in this study makes the process of determining the MQ-series gas sensor circuit parameters less cumbersome as their value can easily be obtained from the resulting graphs. Conclusions: a structured graphical approach for determination of MQ-series gas sensor circuit parameters for alarm points in a stand-alone gas alarm system showed that using MQ-4 gas sensor and LPG as the target gas, and for a sensor circuit output voltage of 2 V for alarm point at 1000 ppm of LPG, the corresponding value of R_O, R_S and R_L obtained were 20 kΩ, 30 kΩ, and 20 kΩ respectively. Hence, a structured graphical approach is suitable for determining MQ series gas sensor circuit parameters for a stand-alone gas alarm system under the influence of its associated gases.
Read Article

Other relevant news

SOUTHERN JOURNAL OF SCIENCES

The SOUTHERN JOURNAL OF SCIENCES publishes articles in Chemistry, Physics, Mathematics, Biology, Pharmacy, Medicine, Engineering, Industrial Science, Agriculture, and related interdisciplinary areas and is intended to fill a gap in terms of scientific information worldwide. All manuscripts can be published either in English or Portuguese, with tile, abstracts, and keywords in English. At present, there are NO PUBLICATION FEES. Editors will cover web hosting, open access, DOI number, and other service costs.

We have set high standards for the articles to be published by ensuring strong but fair refereeing by at least two reviewers. We hope that this Journal will provide a forum for disseminating high-quality research in chemistry and related areas and are open to any questions and suggestions. Starting in 2020, the SOUTHERN JOURNAL OF SCIENCES will have two issues per year (June and December).

Thank you very much for choosing the SOUTHERN JOURNAL OF SCIENCES to publish your paper!
Editorial Team

THANK YOU FOR YOUR PRESENCE


It was an honor the have you with us.

Last Cover

Crossref Content Registration logo
Portico logo